Abstract

Author SummaryDuring the B cell immune response, immunoglobulin (Ig) genes are subject to a unique mutation process known as somatic hypermutation that allows the immune system to generate high-affinity antibodies. Somatic hypermutation preferentially affects Ig genes, relative to other genes, and this is important in preventing catastrophic levels of general genomic mutations that could lead to B cell cancers. We hypothesized that this preferential targeting of somatic hypermutation is assisted by specific DNA sequences in or near Ig genes that focus the action of the mutation machinery on those genes. In this study, we show that Ig genes across species—from human, mouse, and chicken—do indeed contain such mutation targeting sequences and that they coincide with transcriptional regulatory regions known as enhancers. We show that combinations of Ig enhancers cooperate to achieve strong mutation targeting and that this action depends on well-known transcription factor binding sites in these enhancer elements. Our findings establish an evolutionarily conserved function for enhancers in somatic hypermutation targeting, which operates by a mechanism distinct from the conventional enhancer function of increasing levels of transcription. We propose that combinations of Ig enhancers target somatic mutation to Ig genes by recruiting the mutation machinery and/or by making the Ig genes better substrates for mutation.

Highlights

  • The appearance of point mutations within the rearranged immunoglobulin (Ig) genes of B cells, which leads eventually to the selection and production of high-affinity antibodies, is called somatic hypermutation (SH) [1,2]

  • Somatic hypermutation preferentially affects Ig genes, relative to other genes, and this is important in preventing catastrophic levels of general genomic mutations that could lead to B cell cancers

  • We hypothesized that this preferential targeting of somatic hypermutation is assisted by specific DNA sequences in or near Ig genes that focus the action of the mutation machinery on those genes

Read more

Summary

Introduction

The appearance of point mutations within the rearranged immunoglobulin (Ig) genes of B cells, which leads eventually to the selection and production of high-affinity antibodies, is called somatic hypermutation (SH) [1,2]. SH requires transcription of the Ig genes [3] and expression of the activation-induced cytidine deaminase (AID) protein encoded by the AICDA gene [4,5]. Pioneering experiments using chimeric gene constructs in transgenic mice indicated that sequences overlapping with the Ig light chain and Ig heavy chain enhancers distinguish the Ig genes as mutation targets [13,14,15]. Other early transgene studies indicated that Ig V region sequences themselves are not required for SH [16] and that active heterologous promoters can support SH [13,17]. Further insight into the nature of the putative cis-acting regulatory elements was hampered by the laborious transgene experimental system, the relatively low mutation rates of the chimeric genes, and the fluctuation of mutation rates among transgenic lines, perhaps due to integration site effects and copy number variations. A further problem arose from the fact that the putative hypermutation-stimulating sequences included the known enhancers, making it difficult to differentiate between the effects of these sequences on transgene hypermutation versus transgene transcription (reviewed in [18])

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call